Treatment Registry
TR-0038 ActiveRecorded August 31, 2026Last verified September 2, 2026

Compounded tirzepatide

Sold by bmiMD · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$249

Medication · 1-month plan$249

Added from the figures recorded below.

Price

TermPer monthCharged today
1-month plan

12 mo $349.20/mo $179 /month ... 1 mo $349.20/mo $249 /month

source, read August 31, 2026

Per month$249Charged today$249
12-month plan

12 mo $349.20/mo $179 /month ... 1 mo $349.20/mo $249 /month

source, read August 31, 2026

Per month$179Charged today$2,148
Enroll with bmiMD

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

  1. August 31, 2026$249 · imported observation, no quote of ours
  2. September 2, 2026$249
  • August 31, 2026Entry added to the register

Sourcing and terms

PharmacyPrecision Compounding Pharmacy, 2657 Merrick Road, Bellmore, NY, named in the terms of use
StatesNot disclosed as of September 3, 2026
PrescriberAsynchronous review
Cancellation“You can cancel/pause your subscription at any time from your account by logging into https://account.bmimd.com/my-account/subscriptions/ , except if you have already been charged for another month of the current program.”
Consult feeNot disclosed as of August 31, 2026

Not yet checked: membership.

Recorded from bmimd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. August 31, 2026BmiMD's 'microdose' pages charge the same live prices as its full-dose pages; only the struck-through comparison figure changes. The semaglutide microdose page reads "12 mo $199.80/mo $119 /month ... 6 mo $199.80/mo $129 /month ... 3 mo $199.80/mo $149 /month ... 1 mo $199.80/mo $159 /month". The tirzepatide microdose page reads "12 mo $299.70/mo $179 /month ... 1 mo $299.70/mo $249 /month". Every live price on both microdose pages matches the corresponding full-dose page exactly; only the struck-through figure differs.
  2. 2. August 31, 2026BmiMD's own home page prices its ready-to-ship tirzepatide and semaglutide two different ways in two different rails. The best-sellers rail reads "Ready to Ship Compounded Tirzepatide Starting as low as $349.20/mo $179/mo" and "Ready to Ship Compounded Semaglutide Starting as low as $228.60/mo $119/mo". Further down, the weight-loss-treatments rail on that same page reads "Ready to Ship Compounded Tirzepatide As low as $299.70/mo $179/month" and "Ready to Ship Compounded Semaglutide As low as $199.80/mo $119/month".
  3. 3. August 31, 2026BmiMD advertises a flat 10 percent subscription discount on its weight-loss pricing page, but most of the twelve plan rows don't actually work out to that rate. Under GLP-1 Plans: "12 Month ... Subscribe & Save $168.49 $149.40/month Save 10% with your subscription ... One-Time Purchase $168.49/month $2,021.99 total", then "$203.99 $179.33/month ... $1,223.99 total", "$219.99 $189/month ... $659.97 total", "$283.99 $228.60/month". Under GLP-1/GIP Microdose: "$280.50 $250.20/month ... $3366 total", "$306 $270.83/month ... $1836 total", "$321 $279.90/month ... $963 total", "$362.99 $299.70/month". Under GLP-1 Microdose: "$170.50 $151.20/month ... $2046 total", "$200 $180/month ... $600 total", "$211/ $189.90/month ... $633 total", "$222 $199.80/month". Every one of the twelve rows carries the same claim, "Save 10% with your subscription. Discount applied at checkout", but only three of them are exactly ten percent - $200 to $180, $211 to $189.90, $222 to $199.80. The other nine work out to 11.3%, 12.1%, 14.1%, 19.5%, 10.8%, 11.5%, 12.8%, 17.4% and 11.3%.
  4. 4. August 31, 2026The arithmetic error, from the same page and the same read: under GLP-1 Microdose the second rung reads "One-Time Purchase $200/month $600 total" beneath a "6 Months" tab. Six months at $200 is $1,200. The 12-month rung on that table ($170.50 × 12 = $2,046) and the 3-month rung ($211 × 3 = $633) both multiply out correctly.
  5. 5. August 31, 2026BmiMD's headline cards advertise two prices that never show up in its own comparison tables below them. The cards read: "Personalized GLP-1 Treatments Starting as low as $233/mo", "GLP-1/GIP Microdose Starting as low as $215.2/mo", "GLP-1 Microdose Starting as low as $215.2/mo". Neither $233 nor $215.2 appears in any of the three tables below them. The same page also lists "Zepbound® (Tirzepatide) Starting as low as $233/mo", "Mounjaro® (Tirzepatide) Starting as low as $249/mo", "Ozempic® (Semaglutide) Starting as low as $249/mo" and "Zepbound® prescription online(vials) Starting as low as $99/mo GLP-1 Lily Direct" — their spelling.
  6. 6. August 31, 2026BmiMD names its fulfillment pharmacy but not the rest of its network. Its terms of use state: "Our fulfillment pharmacy information: Precision Compounding Pharmacy – 2657 Merrick Road, Bellmore, NY 11710 (P: 516-833-6262) Medccm Inc. sources its prescription medication from licensed 503a compounding pharmacies. We typically use the compounding pharmacies listed below, and the specific pharmacy we use depends on the state where the client is located." No list follows that sentence; the next heading is Limited Use and Availability. The same terms say "NO REFUNDS FOR PRODUCTS THAT HAVE ALREADY SHIPPED FROM THE FULFILLMENT PHARMACIES" and allow cancellation "up to forty-eight (48) hours before the applicable monthly processing date".

1 further note concerns other bmiMD programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0038
Readings
2

Related records

What else bmiMD sells

All bmiMD programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). bmiMD compounded tirzepatide (TR-0038). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0038

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.